$GERN News Charting the latest market whipsaw 10

$GERN News

Charting the latest market whipsaw 10:59 a.m. Today - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Amylin and Alkermes shine in drug-stocks trading 2:08 p.m. July 8, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Regeneron, Cephalon boost biotech stocks 2:29 p.m. May 2, 2011 - Val Brickates Kennedy
Stem cell researchers gain on U.S. court decision 9:14 a.m. May 2, 2011 - Val Brickates Kennedy
StemCells shares climb on spinal injury study 2:49 p.m. March 14, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:09 p.m. Dec. 7, 2010 - Kate Gibson


Interesting GERN Call Options For January 2016 12:44 p.m. Today - TheStreet.com
Geron: Hold Or Take Profits Now? 10:17 a.m. Today - Seeking Alpha
Geron Q3 Loss in Line; Shares Up on ASH Abstract - Analyst Blog 10:00 a.m. Today - Zacks.com
Geron: A Changed Company With Significant Potential 9:59 a.m. Today - Seeking Alpha
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
The 10 Dumbest Things This Friday 12:14 p.m. Nov. 8, 2013 - 247WallSt.com
Geron's Promising News Poses No Threat To Incyte 11:53 a.m. Nov. 8, 2013 - Seeking Alpha
Interesting GERN Put And Call Options For January 2015 11:08 a.m. Nov. 8, 2013 - TheStreet.com
Geron Corporation (GERN) Is Today's Perilous Reversal Stock 9:46 a.m. Nov. 8, 2013 - TheStreet.com
Key Issues Surrounding The Zalicus Catalyst Trade 8:56 a.m. Nov. 8, 2013 - Seeking Alpha
Quick Take On Geron's Imetelstat Abstract 9:17 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Management Discusses Q3 2013 Results - Earnings Call Transcript 7:10 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Corporation Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Move Seems Hard To Interpret As Sustainable 3:08 p.m. Nov. 7, 2013 - 247WallSt.com
Geron Revealed Positive Imetelstat Results Amidst Data Concerns 12:10 p.m. Nov. 7, 2013 - benzinga.com
Facebook Tests Star-Rating System for Users and 2 Other Hot Stocks to Watch 11:41 a.m. Nov. 7, 2013 - Wall St. Cheat Sheet
Geron's Imetelstat Data in Myelofibrosis: 4 CRs, 1 PR. But Are These Responses Real? (Update) 10:04 a.m. Nov. 7, 2013 - TheStreet.com
Today's Dead Cat Bounce Stock Is Geron Corporation (GERN) 9:45 a.m. Nov. 7, 2013 - TheStreet.com
Geron: Super Important Imetelstat Data Coming Thursday 7:08 a.m. Nov. 5, 2013 - TheStreet.com
First Week Of June 2014 Options Trading For Geron (GERN) 11:28 a.m. Oct. 23, 2013 - TheStreet.com


Earning Forecast Tips for Hot Stocks: Facebook, Tesla, J.C. Penney, Groupon, Geron, and Alcoa 9:00 a.m. Nov. 8, 2013 - PR Newswire
TrendingWallStreet.com Initiates Volume Analysis on TWTR, FNMA, SEEK, and GERN 12:19 a.m. Nov. 8, 2013 - ACCESSWIRE
Geron Corporation Reports Third Quarter 2013 Financial Results 4:11 p.m. Nov. 7, 2013 - Thomson Reuters ONE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Geron Announces Conference Call to Discuss Third Quarter 2013 Financial Results 3:01 p.m. Nov. 1, 2013 - Thomson Reuters ONE
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 8:00 a.m. Oct. 31, 2013 - PR Newswire
Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences 7:00 a.m. Oct. 21, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 8:26 a.m. Oct. 8, 2013 - PR Newswire
TSLA, AGNC, GERN and ZLCS added to Nasdaq Active Stock Watch List at GSR 8:05 a.m. Oct. 1, 2013 - ACCESSWIRE
Geron Completes Divestiture of Stem Cell Assets 8:01 a.m. Oct. 1, 2013 - Thomson Reuters ONE
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron's Embryonic Stem Cell Assets 8:00 a.m. Oct. 1, 2013 - BusinessWire
FSLR, LINE, GERN and CLDX added to NASDAQ Active Stock Watch List at EPR 8:05 a.m. Sept. 24, 2013 - ACCESSWIRE
Edge Therapeutics Elects Robert J. Spiegel, MD To Board of Directors 5:30 a.m. Sept. 10, 2013 - BusinessWire
Geron to Present at the Stifel Healthcare Conference 3:00 p.m. Sept. 4, 2013 - Thomson Reuters ONE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, GERN, NKTR and NPSP 8:01 a.m. Aug. 12, 2013 - ACCESSWIRE
Geron Corporation Reports Second Quarter 2013 Financial Results 3:06 p.m. Aug. 8, 2013 - Thomson Reuters ONE
Geron Announces Conference Call to Discuss Second Quarter 2013 Financial Results 3:31 p.m. July 29, 2013 - Thomson Reuters ONE
Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope 9:56 a.m. July 29, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GERN, IMMU and ITMN 7:48 a.m. July 2, 2013 - ACCESSWIRE
Early Morning Insight: Arena Pharmaceuticals, Geron, Celgene, Incyte, and Spectrum Pharmaceuticals 7:59 a.m. June 25, 2013 - PR Newswire